Torrent Pharma's Dahej Plant receives EIR from FDA
21 March 2016 | News | By BioSpectrum Bureau
Torrent Pharma's Dahej Plant receives EIR from FDA
This plant is now the 3rd plant of Torrent Pharma to receive FDA approval
Prior to this approval, the Plant has also received approval from EU Germany. It was set up to cater mainly to the regulated international markets such as US, Brazil, Germany etc.
With the approval, this plant is now the 3rd plant of Torrent Pharma to receive US FDA approval, out of its 5 manufacturing units. The company's other US FDA approved plant include the Plant at Indrad, Gujarat and Pithampur (Indore), MP.
The plant is spread across 70 acres with a built up area of around 97000 sq. mtr. Phase I has an installed capacity of about 7,500 million tablets / capsules and 25 MT API per annum.
As per the company, Construction of Phase II will commence soon and once commissioned the total capacity will increase to about 14,000 million tablets / capsules and 80 MT API per year.
